Common Stock, Shares, Outstanding of Editas Medicine, Inc. from 31 Dec 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Editas Medicine, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2015 to 31 Dec 2025.
  • Editas Medicine, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 97,866,996, a 18% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Editas Medicine, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 97,866,996 +15,132,300 +18% 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q3 2025 93,264,421 +10,725,797 +13% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 87,388,425 +4,958,911 +6% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 83,709,536 +1,474,585 +1.8% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 82,734,696 +967,433 +1.2% 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q3 2024 82,538,624 +869,828 +1.1% 30 Sep 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 82,429,514 +812,605 +1% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 82,234,951 +13,241,360 +19% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 81,767,263 +12,919,881 +19% 31 Dec 2023 10-K 05 Mar 2025 2024 FY
Q3 2023 81,668,796 +12,907,067 +19% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 81,616,909 +12,898,475 +19% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 68,993,591 +390,927 +0.57% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 68,847,382 +412,125 +0.6% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 68,761,729 +441,070 +0.65% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 68,718,434 +558,648 +0.82% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 68,602,664 +1,130,049 +1.7% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 68,435,257 +5,871,800 +9.4% 31 Dec 2021 10-K 22 Feb 2023 2022 FY
Q3 2021 68,320,659 +6,132,959 +9.9% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 68,159,786 +6,056,137 +9.8% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 67,472,615 +12,670,216 +23% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 62,563,457 +8,207,659 +15% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 62,187,700 +11,111,502 +22% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 62,103,649 +12,862,556 +26% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 54,802,399 +5,879,277 +12% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 54,355,798 +5,596,847 +11% 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q3 2019 51,076,198 +3,572,589 +7.5% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 49,241,093 +1,888,340 +4% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 48,923,122 +2,211,427 +4.7% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 48,758,951 +4,250,991 +9.6% 31 Dec 2018 10-K 26 Feb 2020 2019 FY
Q3 2018 47,503,609 +5,663,487 +14% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 47,352,753 +6,439,335 +16% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 46,711,695 +5,999,399 +15% 31 Mar 2018 10-Q 04 May 2018 2018 Q1
Q4 2017 44,507,960 +8,689,829 +24% 31 Dec 2017 10-K 01 Mar 2019 2018 FY
Q3 2017 41,840,122 +6,231,485 +18% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 40,913,418 +5,539,728 +16% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 40,712,296 +5,542,454 +16% 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 35,818,131 +32,584,493 +1008% 31 Dec 2016 10-K 08 Mar 2018 2017 FY
Q3 2016 35,608,637 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 35,373,690 30 Jun 2016 10-Q 10 Aug 2016 2016 Q2
Q1 2016 35,169,842 31 Mar 2016 10-Q 13 May 2016 2016 Q1
Q4 2015 3,233,638 31 Dec 2015 10-K 03 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.